Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
13 studies found for:    m12-630
Show Display Options
Rank Status Study
1 Recruiting A Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Combination With Bendamustine/Rituximab (BR) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: ABT-199;   Drug: Bendamustine;   Drug: Rituximab
2 Unknown  Per-cutaneous Intervention Based Paclitaxel and Sirolimus-Eluting Versus Bare Stents for the Treatment of de Novo Coronary Lesions (PAINT)
Condition: Coronary Restenosis
Interventions: Device: Milennium Matrix® (Control);   Device: Infinnium®;   Device: Supralimus®
3 Active, not recruiting Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Condition: Atherosclerosis
Interventions: Drug: Canakinumab;   Drug: Placebo
4 Recruiting Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy
Condition: Colon Cancer
Intervention: Drug: oxaliplatin
5 Completed A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithromycin in Pediatric Subjects With Acute Otitis Media
Condition: Acute Otitis Media
Interventions: Drug: cefdinir (Omnicef);   Drug: azithromycin
6 Recruiting The International Nocturnal Oxygen (INOX) Trial
Conditions: Chronic Obstructive Pulmonary Disease;   Nocturnal Desaturation
Interventions: Device: Concentrator;   Device: Sham concentrator
7 Completed
Has Results
Dabigatran Etexilate for Stroke Prevention in Patients With Atrial Fibrillation and Mild to Moderate Renal Impairment
Condition: Atrial Fibrillation
Intervention:
8 Active, not recruiting Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: cabazitaxel, prednisone, custirsen sodium;   Drug: cabazitaxel, prednisone
9 Recruiting Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim2)
Condition: Insulin Sensitivity
Interventions: Drug: Maltodextrin;   Drug: Synbiotic;   Drug: Sevelamer
10 Recruiting A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer
Condition: Lung Neoplasms
Intervention: Radiation: Radiation Concurrent Chemotherapy
11 Recruiting A 12 Week, 3-Period Study to Evaluate the Effects of a Dietary Supplement on Lipid Metabolism
Condition: Hyperlipidemia
Interventions: Dietary Supplement: Placebo;   Dietary Supplement: Low Dose Grape Blend;   Dietary Supplement: High Dose Grape Blend
12 Recruiting Bioavailability of EPA and DHA From Two Dietary Supplements
Condition: Hypertriglyceridemia
Intervention: Dietary Supplement: DHA-rich fish oil versus Phospholipid-rich fish oil
13 Recruiting Venlafaxine PK Following Bariatric Surgery
Conditions: Roux en Y Gastric Bypass;   Sleeve Gastrectomy
Intervention: Drug: Venlafaxine IR and Venlafaxine XR

Indicates status has not been verified in more than two years